학술논문
Social prescribing for people living with dementia (PLWD) and their carers: what works, for whom, under what circumstances and why - protocol for a complex intervention systematic review.
Document Type
Academic Journal
Author
Marshall J; Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.; Papavasiliou E; University of Leeds, Leeds, UK.; Fox C; University of Exeter, Exeter, UK.; Hawkes M; University of East Anglia, Norwich, UK.; Irvine A; University of East Anglia, Norwich, UK.; Moniz-Cook E; University of Hull, Hull, UK.; Pick A; University of Newcastle upon Tyne, Newcastle upon Tyne, UK.; Polley MJ; Meaningful Measures Ltd, Bristol, UK.; Reeve J; Hull York Medical School, Hull, UK.; Robinson L; Institute for Health and Society, Newcastle University, Newcastle, UK.; Rook G; Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.; Sadler E; Faculty of Environmental and Life Sciences, School of Health Sciences, University of Southampton, Southampton, UK.; Wolverson E; Faculty of Health Sciences, University of Hull, Hull, UK.; Walker S; University of Exeter, Exeter, UK.; Cross JL; University of East Anglia, Norwich, UK j.cross@uea.ac.uk.
Source
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Subject
Language
English
Abstract
Introduction: Dementia is a complex medical condition that poses significant challenges to healthcare systems and support services. People living with dementia (PLWD) and their carers experience complex needs often exacerbated by social isolation and challenges in accessing support. Social prescribing (SP) seeks to enable PLWD and their carers to access community and voluntary sector resources to support them address such needs. Existing research, however, does not describe what SP interventions are currently in place in dementia care. Little is known about the needs these interventions are designed to address, the reasons that lead PLWD and their carers to participate in them, their effectiveness and the extent to which they could increase positive health outcomes if adopted and how.
Methods and Analysis: A complex intervention systematic review of SP for PLWD and/or their carers will be conducted using an iterative logic model approach. Six electronic (MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus and Cochrane/CENTRAL) and two grey literature databases (EThOS and CORE) were searched for publications between 1 January 2003 and June 2023, supplemented by handsearching of reference lists of included studies. Study selection, data extraction and risk of bias assessment, using Gough's Weight of Evidence Framework, will be independently performed by two reviewers. A narrative approach will be employed to synthesise and report quantitative and qualitative data. Reporting will be informed by the Preferred Reporting Items for Systematic Review and Meta-Analysis Complex Interventions extension statement and checklist.
Ethics and Dissemination: No ethical approval is required due to this systematic review operating only with secondary sources. Findings will be disseminated through peer-reviewed publications, conference presentations and meetings with key stakeholders including healthcare professionals, patient and carer groups, community organisations (eg, the Social Prescribing Network and the Evidence Collaborative at the National Academy for Social Prescribing), policymakers and funding bodies.
Prospero Registration Number: CRD42023428625.
Competing Interests: Competing interests: Minor competing interest declared by co-author (EMC) regarding salary costs from the sponsor funded by the NIHR.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
Methods and Analysis: A complex intervention systematic review of SP for PLWD and/or their carers will be conducted using an iterative logic model approach. Six electronic (MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus and Cochrane/CENTRAL) and two grey literature databases (EThOS and CORE) were searched for publications between 1 January 2003 and June 2023, supplemented by handsearching of reference lists of included studies. Study selection, data extraction and risk of bias assessment, using Gough's Weight of Evidence Framework, will be independently performed by two reviewers. A narrative approach will be employed to synthesise and report quantitative and qualitative data. Reporting will be informed by the Preferred Reporting Items for Systematic Review and Meta-Analysis Complex Interventions extension statement and checklist.
Ethics and Dissemination: No ethical approval is required due to this systematic review operating only with secondary sources. Findings will be disseminated through peer-reviewed publications, conference presentations and meetings with key stakeholders including healthcare professionals, patient and carer groups, community organisations (eg, the Social Prescribing Network and the Evidence Collaborative at the National Academy for Social Prescribing), policymakers and funding bodies.
Prospero Registration Number: CRD42023428625.
Competing Interests: Competing interests: Minor competing interest declared by co-author (EMC) regarding salary costs from the sponsor funded by the NIHR.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)